NCI
In Brief This Week: Quest Diagnostics; Centogene; Exact Sciences; Eiger Diagnostics
News items for the week of Aug. 28, 2023.
Sylvester Comprehensive Cancer Center Wins $2.5M NCI Grant to Develop Prostate Cancer Test
The team will work with collaborators at Bio-Techne's Exosome Diagnostics to develop its prostate cancer biomarker on a new platform.
NIH Launches New Childhood Cancer Genomics Program
Pediatric and young adult patients treated at facilities affiliated with the NCI-sponsored Children's Oncology Group gain new, broad access to tumor molecular profiling.
Castle Biosciences Working With NCI on SEER Registry Study of DecisionDx-Melanoma
A first data analysis has shown patients with DecisionDx-Melanoma testing had better overall survival rates than those who were not tested.
President Biden Jumpstarts Cancer Moonshot Initiative With Goal of Halving Death Rate
The renewal of the ambitious effort includes the reestablishment of direct White House leadership, with a cross-agency cabinet to drive progress in early detection and care equity.
Jan 29, 2019
Jan 17, 2019
Jan 17, 2019
Nov 19, 2018
Sep 24, 2018